QUANTAIS: The Quantum-Autoimmune Integrated Stack for Next-Generation Immunomodulation

QUANTAIS is a five-layer, plug-and-play research and clinical platform that couples cutting-edge quantum processors, nano-sensing arrays, and AI-driven analytics to observe, perturb, and ultimately program quantum chemical events that tip immune cells toward auto-immunity. By streaming real-time redox and spin-state data from living cells into entanglement-aware multi-omics pipelines, and feeding those insights back into adaptive spin-field or molecular interventions, QUANTAIS promises a closed-loop path from femtosecond quantum dynamics to patient-level disease control. A global consortium anchored by MIT, Harvard, UCLA, ETH Zürich, and RIKEN underwrites the hardware, biology, and ethics infrastructure, while the NEAR-ONE meta-layer drives fidelity toward the “five nines” required for clinical deployment.